Conduct a Phase II macroeconomic study to evaluate the economic potential and market impact of cell and gene therapy technologies.
Contract awarded. Originally published 3 weeks ago.
Only 1 prior award here — too little to read.
In research innovation, CELL THERAPY CATAPULT LIMITED has awarded 1 contract to 1 supplier.
Across research innovation, the most active winners are IPSOS MARKET RESEARCH LIMITED, WSP UK LIMITED, Silvijus Abramavičius — the field to beat, or your route in as a partner.
12-month corporate subscription to technical and industrial standards and documentation databases, valued at £43,858.70.
Install and qualify a Pharmagraph pEMS system in Module 7 and QC Laboratory at CGTC Stevenage Manufacturing Innovation Centre between June and October 2026 for £195,954.48.
Supplier contract needed to provide security services and personnel for the Braintree facility.
CGT Catapult requires continued support and maintenance for its Securecell AG Numera and Lucullus automation platform through a direct award contract with the sole provider.
UKRI is funding up to £2m three-year research projects to improve understanding and prevention of gambling-related harms through interdisciplinary collaboration.
UK biomedical researchers can apply for up to £1 million in MRC funding to purchase a single piece of mid-range capital equipment by 31 December 2027.
UKRI is offering up to £60 million over seven years for a director-led research institute to investigate obesity and cardiometabolic disease mechanisms with translation to prevention and treatment strategies.
EPSRC-funded NetworkPlus bringing together researchers, industry, and communities to develop a roadmap for increasing UK property flood resilience adoption.
